103 related articles for article (PubMed ID: 24878535)
1. Identification of lysosomotropic compounds based on the distribution and size of lysosomes.
Seo I; Jha BK; Lim JG; Suh SI; Suh MH; Baek WK
Biochem Biophys Res Commun; 2014 Jul; 450(1):189-94. PubMed ID: 24878535
[TBL] [Abstract][Full Text] [Related]
2. A high content screening assay for identifying lysosomotropic compounds.
Nadanaciva S; Lu S; Gebhard DF; Jessen BA; Pennie WD; Will Y
Toxicol In Vitro; 2011 Apr; 25(3):715-23. PubMed ID: 21184822
[TBL] [Abstract][Full Text] [Related]
3. Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function.
Pisonero-Vaquero S; Medina DL
Curr Drug Metab; 2017; 18(12):1147-1158. PubMed ID: 28952432
[TBL] [Abstract][Full Text] [Related]
4. In Vitro and in Silico Tools To Assess Extent of Cellular Uptake and Lysosomal Sequestration of Respiratory Drugs in Human Alveolar Macrophages.
Ufuk A; Assmus F; Francis L; Plumb J; Damian V; Gertz M; Houston JB; Galetin A
Mol Pharm; 2017 Apr; 14(4):1033-1046. PubMed ID: 28252969
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of lysosomal sequestration in the mechanistic model for prediction of tissue distribution of basic drugs.
Assmus F; Houston JB; Galetin A
Eur J Pharm Sci; 2017 Nov; 109():419-430. PubMed ID: 28823852
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal adaptation: How cells respond to lysosomotropic compounds.
Lu S; Sung T; Lin N; Abraham RT; Jessen BA
PLoS One; 2017; 12(3):e0173771. PubMed ID: 28301521
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes.
Logan R; Kong A; Krise JP
J Pharm Sci; 2013 Nov; 102(11):4173-80. PubMed ID: 23970383
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts.
Logan R; Kong AC; Krise JP
J Pharm Sci; 2014 Oct; 103(10):3287-96. PubMed ID: 25042198
[TBL] [Abstract][Full Text] [Related]
9. Influence of lipophilicity and lysosomal accumulation on tissue distribution kinetics of basic drugs: a physiologically based pharmacokinetic model.
Yokogawa K; Ishizaki J; Ohkuma S; Miyamoto K
Methods Find Exp Clin Pharmacol; 2002 Mar; 24(2):81-93. PubMed ID: 12040887
[TBL] [Abstract][Full Text] [Related]
10. Extension of the Mechanistic Tissue Distribution Model of Rodgers and Rowland by Systematic Incorporation of Lysosomal Trapping: Impact on Unbound Partition Coefficient and Volume of Distribution Predictions in the Rat.
Schmitt MV; Reichel A; Liu X; Fricker G; Lienau P
Drug Metab Dispos; 2021 Jan; 49(1):53-61. PubMed ID: 33148688
[TBL] [Abstract][Full Text] [Related]
11. Quantification of Intracellular Accumulation and Retention of Lysosomotropic Macrocyclic Compounds by High-Throughput Imaging of Lysosomal Changes.
Easwaranathan A; Inci B; Ulrich S; Brunken L; Nikiforova V; Norinder U; Swanson S; Munic Kos V
J Pharm Sci; 2019 Jan; 108(1):652-660. PubMed ID: 30419273
[TBL] [Abstract][Full Text] [Related]
12. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis.
Zhitomirsky B; Assaraf YG
Oncotarget; 2017 Jul; 8(28):45117-45132. PubMed ID: 28187461
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of Lysosomal Trapping of Basic Lipophilic Compounds Using In Vitro Assays and In Silico Predictions Based on the Determination of the Full pH Profile of the Endo-/Lysosomal System in Rat Hepatocytes.
Schmitt MV; Lienau P; Fricker G; Reichel A
Drug Metab Dispos; 2019 Jan; 47(1):49-57. PubMed ID: 30409837
[TBL] [Abstract][Full Text] [Related]
15. Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study.
Logan R; Kong AC; Axcell E; Krise JP
J Pharm Sci; 2014 May; 103(5):1572-80. PubMed ID: 24647827
[TBL] [Abstract][Full Text] [Related]
16. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
Logan R; Funk RS; Axcell E; Krise JP
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):943-58. PubMed ID: 22616667
[TBL] [Abstract][Full Text] [Related]
17. Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping.
Daniel WA; Wójcikowski J; Pałucha A
Br J Pharmacol; 2001 Oct; 134(4):807-14. PubMed ID: 11606321
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the mechanism of subcellular distribution of basic drugs based on their lipophilicity].
Ishizaki J; Yokogawa K; Ohkuma S; Ichimura F; Miyamoto K
Yakugaku Zasshi; 2001 Jul; 121(7):557-65. PubMed ID: 11494600
[TBL] [Abstract][Full Text] [Related]
19. Effect of lysosomotropic molecules on cellular homeostasis.
Kuzu OF; Toprak M; Noory MA; Robertson GP
Pharmacol Res; 2017 Mar; 117():177-184. PubMed ID: 28025106
[TBL] [Abstract][Full Text] [Related]
20. Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.
Funk RS; Krise JP
Mol Pharm; 2012 May; 9(5):1384-95. PubMed ID: 22449202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
